Effects of carbamazepine on hippocampal serotonergic system

Epilepsy Research

Volumn 31, Issue 3, 1998, Pages 187-198

  Okada, Motohiro ^a   Hirano, Takayuki ^b   Mizuno, Kazuhisa ^a   Kawata, Yuko ^a   Wada, Kazumaru ^a   Murakami, Takuya ^a   Tasaki, Hiroichi ^a   Kaneko, Sunano ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b National Hospital Organization Hanamaki Hospital   (Japan)

Author keywords

Carbamazepine; Epilepsy; Microdialysis; Serotonin metabolism; Serotonin release

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; CARBAMAZEPINE; SEROTONIN;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG MECHANISM; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM;

5-HYDROXYTRYPTOPHAN; ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; RATS; RATS, WISTAR; SEROTONIN;

EID: 0031855203     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00025-4     Document Type: Article

References (38)

1. Browning, R.A., 1987. The role of neurotransmitters in electricshock seizure models. In: Jobe, P.C., Laird, H.E. II (Eds.), Neurotransmitter and Epilepsy. Humana Press, Clifton, NJ, pp. 277-320.
2. Buus Lassen L. Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors. Eur. J. Pharmacol. 47:1997;351-358.
3. Chaupt Y., de Montigny C., Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatment. An in vivo electrophysiologic study in the rat. Neuropharmacology. 5:1991;219-229.
4. Colino A., Halliwell J.V. Differential modulation of the three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature. 328:1987;73-77.
5. De la Fuente J.N., Mendlewicz J. Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression. Biol. Psychiatry. 32:1992;369-374.
6. Dursun S.M., Matthew V.M., Reveley M. Toxic serotonin syndrome after fluxetine plus carbamazepine. Lancet. 342:1993;442-443.
7. Elphic M., Anderson S.M.P., Hallis K.F., Granhame-Smith D.G. Effects of carbamazepine on 5-hydroxytryptamine function in rodents. Psychopharmacology. 100:1990;49-53.
8. Fromm G.H., Terrence C.F., Maroon J.C. Trigeminal neuralgia. Current concepts regarding etiology and pathogenesis. Arch. Neurol. 41:1984;1204-1207.
9. Glowinski J., Iversen L. Regional studies of catecholamines in the rat brain. J. Neurochem. 13:1966;665-669.
10. Hashiguti H., Nakahara D., Maruyama W., Naoi M., Ikeda T. Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis. J. Neural Transm. 93:1993;213-223.
11. Hirano T., Kaneko S., Otani K., Kondo T., Sasa H., Fukushima Y. Mechanisms of antimanic effects of zotepine. Neuroscience. 16:1990;511-516.
12. Juergens U. Simultaneous determination of zonisamide and nine other anti-epileptic drugs and metabolites in serum. J. Chromatogr. 385:1987;233-240.
13. Kaneko S., Fukushima Y., Sato T., Hiramatsu M., Mori A. Effects of carbamazepine on catecholamine level in mouse brain. IRCS Med. Sci. 9:1980;80-81.
14. Kaneko S., Okada M., Hirano T., Otani K., Fukushima Y. Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vitro, and carbamazepine does not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread. Jpn. J. Psychiatry Neurol. 47:1993;371-373.
15. Keck P.E.J., McElroy S.L., Friedman L.M. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioural dyscontrol syndromes. J. Clin. Psychopharmacol. 12:1992;36S-41S.
16. Kito M., Maehara M., Watanabe K. Antiepileptic drugs - calcium current interaction in cultured human neuroblastoma cells. Seizure. 3:1994;141-149.
17. Leander J.D. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effect of phenytoin, carbamazepine, and ameltolide (LY20116). Epilepsia. 33:1992;573-576.
18. Loiseau, P., Duche, B., 1995. Carbamazepine, clinical use. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs, 4th ed. Raven Press, New York, pp. 555-566.
19. Macdonald, R.L., 1995. Carbamazepine, mechanisms of action. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs, 4th ed. Raven Press, New York, pp. 491-498.
20. Masuda Y., Utsui Y., Shiraishi Y., Karasawa T., Yoshida K., Shimizu M. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals. Epilepsia. 20:1979;623-633.
21. Mizuno K., Okada M., Kaneko S., Hirano T., Tokinaga N., Chiba T., Otani K., Fukushima Y. Effects of zonisamide, carbamazepine and valproate on monoamine metabolism in rat striatum and hippocampus. Jpn. J. Psychiatry Neurol. 48:1994;406-408.
22. Nelson D.R., Thomas D.R., Johnson A.M. Pharmacological effects of paroxetine after repeated administration to animals. Acta Psychiatr. Scand. 80:1989;21-23.
23. Neppe V.M. Carbamazepine in the psychiatric patient. Lancet. 2:1982;334.
24. 2+ dependent dopamine release. Epilepsy Res. 13:1992;113-119.
25. Okada M., Kaneko S., Hirano T., Mizuno K., Kondo T., Otani K., Fukushima Y. Effects of zonisamide on dopaminergic system. Epilepsy Res. 22:1995;193-205.
26. Okada M., Mizuno K., Kaneko S. Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum. Psychiatr. Clin. Neurosci. 50:1996;147-156.
27. Okada M., Mizuno K., Kaneko S. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212:1996;53-56.
28. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol. 321:1997;181-188.
29. Okada M., Hirano T., Mizuno K., Chiba T., Kawata Y., Kiryu K., Wada K., Tasaki H., Kaneko S. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res. 28:1997;143-153.
30. Okada M., Kawata Y., Kiryu K., Mizuno K., Wada K., Inomata H., Tasaki H., Kaneko S. Effects of non-toxic and toxic concentrations of phenytoin on monoamines levels in rat brain. Epilepsy Res. 28:1997;155-163.
31. Okada M., Kawata Y., Kiryu K., Wada K., Tasaki H., Kaneko S. Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J. Neurochem. 69:1997;2581-2588.
32. Okuma T., Yamashita I., Takahashi R., Itoh H., Otuki S., Watanabe S., Hazama H., Inagawa K. Comparison of the antimanic efficacy of carbamazepine and lithium carbanate by double-blind controlled study. Pharmacopsychiatry. 23:1990;143-150.
33. Pratt J.A., Jenner P., Marsden C.D. Comparison of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5-HT in mouse brain. Neuropharmacology. 24:1985;59-68.
34. Schinder, W., 1960. New N-heterocyclic compounds, US Patent 2,948,718, August 9, 1960.
35. + currents in mammalian myelinated nerve fibers. Epilepsia. 30:1989;286-294.
36. Sharp T., Bramwell S.R., Grahame-Smith D.G. Release of endogenous 5-hydroxy-tryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: sensitivity to tetrodotoxin, calcium and calcium antagonist. Neuroscience. 39:1990;629-637.
37. Yoshimura R., Yanagihara N., Terao T., Minami L., Abe K., Izumi F. Inhibition by carbamazepine of various ion channels - mediated catecholamine secretion in cultured bovine adrenal medullary cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;297-303.
38. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Intra-hippocampal injection of 8-hydroxy-2(di-n-propylamino) tetralin (8-OH-DPAT) inhibits partial and generalized seizure induced by kindling stimulation in cats. Neurosci. Lett. 159:1993;179-182.